Vitamin D can reduce severity and spread of COVID-19

In a recent study published in the Scientific Reports journal, researchers in the United States assessed the relationship between supplementation with vitamin D and coronavirus disease 2019 (COVID-19) and related mortality.

Vitamin D deficiency has long been linked to impaired immunological function, which can result in viral infection. In addition, multiple studies have demonstrated that vitamin D deficiency is related to an increased risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, it is unclear whether Vitamin D therapy can lessen the likelihood of COVID-19 infection.

Study: Association between vitamin D supplementation and COVID-19 infection and mortality. Image Credit: Kozachenko Oleksandr / ShutterstockStudy: Association between vitamin D supplementation and COVID-19 infection and mortality. ​​​​​​​Image Credit: Kozachenko Oleksandr / Shutterstock

About the study

In the present study, researchers performed a large-scale pharmacoepidemiologic investigation to determine the relationship between vitamin D2 and D3 supplementation and the risk of COVID-19 infection-related mortality within 30 days.

The team conducted a retrospective cohort analysis to assess the relationship between vitamin D2 and D3 supplementation and SARS-CoV-2 infection and death. The association was determined using a cohort of veterans affairs (VA) patients who were treated with the supplementation with doxercalciferol (vitamin D2), ergocalciferol (vitamin D2), calcifediol (vitamin D3), and oral cholecalciferol (vitamin D3) between the pre-pandemic period from 1 January 2019 to 31 December 2020, and during the pandemic from 1 March 2020 to 31 December 2020. Prior to calculation, the team matched treated with control patients based on their likelihood of consuming vitamin D2 and D3 supplements separately. In addition, a subgroup analyses for D3 was performed to identify treatment heterogeneity according to race, vitamin D level, and mean daily and cumulative supplementing dosage.

Supplementation with vitamin D2 or D3 was the primary exposure prior to and after the pandemic started on 1 March 2020. The reference group consisted of patients who did not receive vitamin D2 or D3 supplementation. l vitamin D2 and D3 products and dosages were incorporated in the Corporate Data Warehouse (CDW) electronic health records, such as multivitamins and combination medications containing vitamin D3. To examine variance in the relationship between supplementation therapy and COVID-19 infection, a categorical variable representing distinct 25-dihydroxycholecalciferol thresholds was constructed.

The primary outcome of the study involved laboratory-confirmed SARS-CoV-2 infection as measured by any Medicare claim or VA medical record having the International Classification of Diseases 10th Revision (ICD-10) code U07.1. COVID-19-associated mortality was also analyzed as a secondary endpoint. The team defined COVID-19-associated mortality as any death occurring within 30 days of infection.

Results

When potential confounding variables were matched, the groups receiving vitamin D3 supplementation and control participants were comparable. A more significant proportion of Black patients were supplemented with vitamin D2 compared to vitamin D3. In general, vitamin D3 recipients experienced more comorbid illnesses than D2 recipients. The vitamin D3 cohort displayed COVID-19 infection rates of 2.66% and 3.30% for the treated and the controls, respectively. Furthermore, the infection rates followed by mortality within 30 days were 0.23% and 0.35% for the treated and the control participants, respectively. The rates of COVID-19 infection that led to mortality in the vitamin D2 group were 0.20% and 0.26% for the treated and the controls within 30 days, respectively.

Compared to untreated controls, vitamin D2 and D3 supplementation during the pandemic reduced the probability of COVID-19 infection by 20% and 28%. Supplementation of vitamin D3 was related to a 33% decreased incidence of COVID-19 infection resulting in 30-day death. However, vitamin D2 results were not statistically significant. Compared to controls, a higher reduction in COVID-19 infection rates was observed among Black patients than White individuals. It was determined that vitamin D serum concentrations inversely correlated with the decline in COVID-19 infection risk.

The overall treatment elicited by vitamin D serum level interaction was considerable, with a 12% rise in the hazard ratio for each category of serum level. A 25% reduction in COVID-19 risk throughout the spectrum of cumulative dosages and a 27% reduction across average daily dosages were also noted. The cumulative dose-response relationship was inversely related to vitamin D blood concentration.

Overall, the study findings showed that vitamin D2 and vitamin D3 supplementation significantly reduced the risk of COVID-19 infection and death within 30 days. Therefore, the researchers believe vitamin D3 supplementation could be a valuable strategy for limiting the spread of COVID-19 infection and related death and racial differences in COVID-19 outcomes.

Journal reference:
Bhavana Kunkalikar

Written by

Bhavana Kunkalikar

Bhavana Kunkalikar is a medical writer based in Goa, India. Her academic background is in Pharmaceutical sciences and she holds a Bachelor's degree in Pharmacy. Her educational background allowed her to foster an interest in anatomical and physiological sciences. Her college project work based on ‘The manifestations and causes of sickle cell anemia’ formed the stepping stone to a life-long fascination with human pathophysiology.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Kunkalikar, Bhavana. (2022, November 15). Vitamin D can reduce severity and spread of COVID-19. News-Medical. Retrieved on January 30, 2023 from https://www.news-medical.net/news/20221115/Vitamin-D-can-reduce-severity-and-spread-of-COVID-19.aspx.

  • MLA

    Kunkalikar, Bhavana. "Vitamin D can reduce severity and spread of COVID-19". News-Medical. 30 January 2023. <https://www.news-medical.net/news/20221115/Vitamin-D-can-reduce-severity-and-spread-of-COVID-19.aspx>.

  • Chicago

    Kunkalikar, Bhavana. "Vitamin D can reduce severity and spread of COVID-19". News-Medical. https://www.news-medical.net/news/20221115/Vitamin-D-can-reduce-severity-and-spread-of-COVID-19.aspx. (accessed January 30, 2023).

  • Harvard

    Kunkalikar, Bhavana. 2022. Vitamin D can reduce severity and spread of COVID-19. News-Medical, viewed 30 January 2023, https://www.news-medical.net/news/20221115/Vitamin-D-can-reduce-severity-and-spread-of-COVID-19.aspx.

Comments

  1. Will MacPheat Will MacPheat United States says:

    It would have been beneficial if the study mentioned outcomes and levels of vitamin D supplementation. There are doctors who have pushed for 5,000 IU's for some time. And there is research that's over a year old that shows that at 50 nanograms per milliliter blood level you have near zero deaths. That same paper says that you need 5,000 IU to achieve that. I have supplemented with 5,000 IU for years and after having my level tested last year went to 7000. I haven't been vaccinated nor has my wife. Everyone where she works except her is vaccinated and has covid. Neither of us have gotten covid despite obviously being exposed to it and the only thing that we have done is maintained high vitamin D levels. And the misinformation folks we're saying this from the early days of the pandemic and yet mainstream media doesn't really seem to want to address it.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
Analysis of adverse events in older US adults after COVID-19 mRNA vaccination